Evidence map›Paper›PMID 38665213›Full record

ArticleFrontiers in toxicology2024

Use of quantitative

Marjory Moreau, Liam Simms, Melvin E Andersen, Edgar Trelles Sticken, Roman Wieczorek, Sarah Jean Pour, Fiona Chapman, Karin Roewer, Sandra Otte, Jeffrey Fisher and 1 more

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Extrapolation steps in quantitativeCurrent research in toxicology · 2026
    Review
  5. The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Optimisation of anFrontiers in toxicology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marjory MoreauScitovation LLC, Durham, NC, United States.
Liam SimmsImperial Brands PLC, Bristol, United Kingdom.
Melvin E AndersenScitovation LLC, Durham, NC, United States.
Edgar Trelles StickenReemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Hamburg, Germany.
Roman WieczorekReemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Hamburg, Germany.
Sarah Jean PourReemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Hamburg, Germany.
Fiona ChapmanImperial Brands PLC, Bristol, United Kingdom.
Karin RoewerReemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Hamburg, Germany.
Sandra OtteReemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Hamburg, Germany.
Jeffrey FisherScitovation LLC, Durham, NC, United States.
Matthew StevensonImperial Brands PLC, Bristol, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the use of

Indexed as

aerosolcigaretteheated tobacco product (HTP)in vitromultiple-path particle dosimetryphysiologically based pharmacokinetic (PBPK) modellingrespiratory toxicity

Identifiers

PMID38665213
PMCPMC11043521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.